D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.09% |
| 2 | Technology | 10.39% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
2701
DELISTED
Select Medical
SEM
| $556K | ﹤0.01% |
+87,423
| New | +$469K |
|
2702
Townsquare Media
TSQ
$107M
| $555K | ﹤0.01% |
49,516
-11,956
| -19% | -$124K |
|
|
ONCE
2703
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $555K | ﹤0.01% |
18,794
-63,305
| -77% | -$2M |
|
|
ADPT
2704
CALL
DELISTED
Adeptus Health Inc
ADPT
| $555K | ﹤0.01% |
10,000
-20,000
| -67% | -$1.03M |
|
2705
Altisource Portfolio Solutions
ASPS
$63.8M
| $554K | ﹤0.01% |
+2,865
| New | +$609K |
|
|
OMN
2706
DELISTED
OMNOVA Solutions Inc.
OMN
| $554K | ﹤0.01% |
99,597
+45,322
| +84% | +$243K |
|
2707
Pathward Financial
CASH
$1.84B
| $553K | ﹤0.01% |
36,408
-10,371
| -22% | -$143K |
|
2708
Renasant Corp
RNST
$4.05B
| $552K | ﹤0.01% |
16,787
+8,015
| +91% | +$255K |
|
|
OSIR
2709
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $552K | ﹤0.01% |
96,621
+77,465
| +404% | +$541K |
|
2710
AudioCodes
AUDC
$246M
| $551K | ﹤0.01% |
118,587
+3,749
| +3% | +$16.1K |
|
2711
Turkcell
TKC
$4.75B
| $551K | ﹤0.01% |
52,394
-104,587
| -67% | -$968K |
|
2712
GameStop
GME
$9.6B
| $550K | ﹤0.01% |
69,304
+20,680
| +43% | +$149K |
|
2713
ESCO Technologies
ESE
$8.39B
| $549K | ﹤0.01% |
14,087
+2,927
| +26% | +$104K |
|
|
HSKA
2714
DELISTED
Heska Corp
HSKA
| $547K | ﹤0.01% |
19,182
+1,964
| +11% | +$65.1K |
|
|
ZAGG
2715
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $546K | ﹤0.01% |
60,602
-21,920
| -27% | -$210K |
|
|
FCB
2716
DELISTED
FCB Financial Holdings, Inc.
FCB
| $546K | ﹤0.01% |
16,402
-759
| -4% | -$24.2K |
|
2717
PUT
Johnson & Johnson
JNJ
$644B
| $541K | ﹤0.01% |
5,000
-141,300
| -97% | -$14.6M |
|
2718
CALL
Universal Display
OLED
$3.71B
| $541K | ﹤0.01% |
10,000
| – | – |
|
|
2719
PUT
Universal Display
OLED
$3.71B
| $541K | ﹤0.01% |
10,000
| – | – |
|
2720
Team
TISI
$80M
| $541K | ﹤0.01% |
1,782
-1,158
| -39% | -$297K |
|
2721
PUT
Golar LNG
GLNG
$4.9B
| $539K | ﹤0.01% |
30,000
-67,700
| -69% | -$1.16M |
|
|
SHOS
2722
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
| $539K | ﹤0.01% |
83,986
+7,954
| +10% | +$53.1K |
|
2723
Skywest
SKYW
$4.27B
| $537K | ﹤0.01% |
26,866
-5,289
| -16% | -$89.4K |
|
|
VR
2724
DELISTED
Validus Hold Ltd
VR
| $537K | ﹤0.01% |
11,388
-45,677
| -80% | -$2.05M |
|
|
FGL
2725
DELISTED
Fidelity & Guaranty Life
FGL
| $533K | ﹤0.01% |
20,330
-13,334
| -40% | -$338K |
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.